Contrast-Induced Nephropathy in Percutaneous Coronary Interventions: Pathogenesis, Risk Factors, Outcome, Prevention and Treatment

Publisher： Karger

E-ISSN： 1421-9751|128|1|62-72

ISSN： 0008-6312

Source： Cardiology, Vol.128, Iss.1, 2014-02, pp. : 62-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention

By  

NEPHROLOGY, Vol. 20, Iss. 8, 2015-08 ,pp. : 544-551

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alpha-Lipoic Acid for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: The ALIVE Study - A Prospective Randomized Trial

By  

Cardiology, Vol. 126, Iss. 3, 2013-08 ,pp. : 159-166

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy

By  

Nephron Clin Pract, Vol. 104, Iss. 1, 2006-05 ,pp. : c20-c27

Karger

Access to resources Recommend Favorite

Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography

By  

Nephron Clin Pract, Vol. 108, Iss. 3, 2008-02 ,pp. : c176-c181

Karger

Access to resources Recommend Favorite

Low-Dose Furosemide Administered with Adequate Hydration Reduces Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography

By  

Cardiology, Vol. 125, Iss. 2, 2013-05 ,pp. : 69-73

Karger

Access to resources Recommend Favorite